LOMA vs MUX

LOMA presents a stark contrast between deterministic value and market expectations. With a Piotroski F-Score of 4/9, the company's financial health is stable but lacks strength, while the current price of $10.86 trades at a massive premium to both the Graham Number ($4.76) and the Intrinsic Value ($1.05). While trailing earnings have collapsed by 82.20%, a significantly lower forward P/E of 12.86 and strong Q/Q revenue growth (26.93%) suggest the market is pricing in a cyclical recovery. The low debt-to-equity ratio provides a safety buffer, but the low quick ratio indicates liquidity is heavily tied up in inventory.

MUX presents a stark contrast between weak deterministic health and explosive growth expectations. The Piotroski F-Score of 3/9 indicates weak financial health, and the current price of $21.03 trades at a significant premium to both the Graham Number ($11.43) and Intrinsic Value ($4.13). However, the company is experiencing massive revenue growth (92.8% YoY) and a very attractive Forward P/E of 4.57, suggesting a pivot toward significant profitability. The stock is currently a high-risk growth play where market sentiment and analyst targets ($31.70) outweigh current fundamental stability.